高草酸尿症与草酸盐肾病的病理生理及管理综述
本文综述高草酸尿症(原发性与继发性)导致草酸钙过饱和、结晶形成,引起尿路结石及肾实质草酸钙沉积(草酸盐肾病)的病理机制。诊断常延迟且预后不佳,原发性高草酸尿症有新型靶向治疗前景;继发性患者常有长期高草酸尿条件,脱水等可触发急性肾损伤。当前标准治疗包括管理病因、高液体摄入和钙剂。
要点
- 高草酸尿症分原发性(肝草酸生成过多)和继发性(肠道吸收增加)。
- 草酸盐肾病诊断常延迟、预后差,早期识别对改善结局至关重要。
- 继发性高草酸尿症患者脱水等可触发急性肾损伤;治疗包括病因管理、高液体摄入和钙剂。
核心结论
- 高草酸尿症可导致尿路结石和草酸盐肾病,及时识别和优化管理可能改善结局。
- 原发性高草酸尿症有新型靶向治疗前景,继发性患者需管理诱发因素。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 原发性高草酸尿症由乙醛酸代谢遗传缺陷导致肝草酸生成过多。
- 继发性高草酸尿症由肠道草酸吸收增加引起。
- 高草酸尿症导致尿草酸钙过饱和和结晶形成,引起尿路结石和肾实质草酸钙沉积。
- 草酸盐肾病诊断常延迟且预后不佳。
- 继发性高草酸尿症患者常有长期高草酸尿条件,脱水等可触发急性肾损伤。
关键数值与推荐
- 当前继发性高草酸尿症标准治疗包括管理病因、高液体摄入和使用钙剂。
临床怎么用
- 对高草酸尿症和草酸盐肾病应尽早识别。
- 继发性高草酸尿症患者需管理病因、保持高液体摄入和使用钙剂。
- 注意脱水等急性肾损伤触发因素。
局限性
- 本文为综述,未报告原始研究数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperoxaluria results from either inherited disorders of glyoxylate metabolism leading to hepatic oxalate overproduction (primary hyperoxaluria), or increased intestinal oxalate absorption (secondary hyperoxaluria). Hyperoxaluria may lead to urinary supersaturation of calcium oxalate and crystal formation, causing urolithiasis and deposition of calcium oxalate crystals in the kidney parenchyma, a condition termed oxalate nephropathy. Considerable progress has been made in the understanding of pathophysiological mechanisms leading to hyperoxaluria and oxalate nephropathy, whose diagnosis is frequently delayed and prognosis too often poor. Fortunately, novel promising targeted therapeutic approaches are on the horizon in patients with primary hyperoxaluria. Patients with secondary hyperoxaluria frequently have long-standing hyperoxaluria-enabling conditions, a fact suggesting the role of triggers of acute kidney injury such as dehydration. Current standard of care in these patients includes management of the underlying cause, high fluid intake, and use of calcium supplements. Overall, prompt recognition of hyperoxaluria and associated oxalate nephropathy is crucial because optimal management may improve outcomes.
引用
- Demoulin N, Aydin S, Gillion V, et al. Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review. Am J Kidney Dis. 2021. PMID: 34508834. doi:10.1053/j.ajkd.2021.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。